Sarepta Therapeutics(CH:AB3A)
CH:AB3A
Sarepta Therapeutics earnings date
Sarepta Therapeutics (AB3A) Q4 2022 Earnings Report
0 Followers
CH:AB3A Q4 2022 EPS Results
- Actual EPS
- -CHF 1.04
- Consensus EPS
- -CHF 1.23
- Beat/Miss
- Beat by +CHF 0.20
- One Year Ago EPS
- -CHF 1.19
CH:AB3A Q4 2022 Revenue Results
- Actual Revenue
- CHF 215.86M
- Expected Revenue
- CHF 209.16M
- Beat/Miss
- Beat by +CHF 6.71M
- YoY Revenue Growth
- +28.28%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/28/2023
- Time
- After Close
- Conference Call
- Tuesday, February 28, 2023
CH:AB3A Upcoming Earnings
Sarepta Therapeutics's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
CH:AB3A Q4 2022 Earnings Call
0:00 / 0:00
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:AB3A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.30- | -3.28 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.07-0.23 | -1.5 | 85.00% (+1.28) | |
| Aug 05, 2026 | 2026 (Q2) | 0.18-0.04 | 1.58 | -102.65% (-1.62) | |
| May 06, 2026 | 2026 (Q1) | 0.822.41 | -3.84 | 162.61% (+6.25) | |
| Feb 25, 2026 | 2025 (Q4) | -1.00-3.28 | 1.25 | -362.00% (-4.54) | |
| Nov 03, 2025 | 2025 (Q3) | -0.61-1.50 | 0.28 | -629.41% (-1.79) | |
| Aug 06, 2025 | 2025 (Q2) | 0.691.58 | 0.06 | 2600.00% (+1.52) | |
| May 06, 2025 | 2025 (Q1) | -2.68-3.84 | 0.31 | -1343.24% (-4.15) | |
| Feb 26, 2025 | 2024 (Q4) | 1.571.25 | 0.39 | 219.15% (+0.86) | |
| Nov 06, 2024 | 2024 (Q3) | -0.060.28 | -0.38 | 173.91% (+0.67) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

